Adrian Schwarzer
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Virus-based gene therapy research
Papers in
-
- RNA Interference and Gene Delivery 7
- CRISPR and Genetic Engineering 7
- Advanced biosensing and bioanalysis techniques 5
- Viral Infectious Diseases and Gene Expression in Insects 4
- Epigenetics and DNA Methylation 4
- Hematology 15
- Acute Myeloid Leukemia Research 14
- Co-authors
- Axel Schambach (19 shared papers)Dirk Heckl (6 shared papers)Inés Avedillo Díez (2 shared papers)Kaan Boztuǧ (2 shared papers)Christoph Klein (2 shared papers)Ricardo A. Dewey (2 shared papers)Sabine Knoess (2 shared papers)Jan‐Henning Klusmann (4 shared papers)
- Journals
- Blood (5 papers)Leukemia (5 papers)PLoS ONE (5 papers)Molecular Therapy (3 papers)Biomaterials (3 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Adrian Schwarzer
43 papers receiving 1.3k citations
Adrian Schwarzer's Hit Papers
Peers
Comparison fields: 5 of 81
- Hematology 200
- Genetics 479
- Oncology 330
- Molecular Biology 853
- Immunology 226
Countries citing papers authored by Adrian Schwarzer
This map shows the geographic impact of Adrian Schwarzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Schwarzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Schwarzer more than expected).
Fields of papers citing papers by Adrian Schwarzer
This network shows the impact of papers produced by Adrian Schwarzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Schwarzer. The network helps show where Adrian Schwarzer may publish in the future.
Co-authors
The 25 scholars most cited alongside Adrian Schwarzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 405 | |
| 2 | Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications Hit paper breakdown → | 2017 | 208 |
| 3 | 2009 | 88 | |
| 4 | 2012 | 56 | |
| 5 | 2011 | 51 | |
| 6 | 2012 | 47 | |
| 7 | 2016 | 36 | |
| 8 | 2021 | 33 | |
| 9 | 2019 | 31 | |
| 10 | 2019 | 30 | |
| 11 | 2011 | 26 | |
| 12 | 2014 | 24 | |
| 13 | 2014 | 22 | |
| 14 | 2014 | 21 | |
| 15 | 2015 | 21 | |
| 16 | 2014 | 20 | |
| 17 | 2017 | 16 | |
| 18 | 2017 | 15 | |
| 19 | 2012 | 15 | |
| 20 | 2012 | 14 |
About Adrian Schwarzer
Adrian Schwarzer is a scholar working on Molecular Biology, Hematology, Genetics, Cancer Research and Oncology, having authored 44 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (14 papers), Virus-based gene therapy research (10 papers), RNA Interference and Gene Delivery (7 papers), CRISPR and Genetic Engineering (7 papers), Advanced biosensing and bioanalysis techniques (5 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers), Epigenetics and DNA Methylation (4 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Hematology (200 citations), Genetics (479 citations), Oncology (330 citations), Molecular Biology (853 citations) and Immunology (226 citations). Adrian Schwarzer has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Axel Schambach, Dirk Heckl, Inés Avedillo Díez, Kaan Boztuǧ, Christoph Klein, Ricardo A. Dewey, Sabine Knoess, Jan‐Henning Klusmann, Felix F. Adams and Michelle Ng. Their work appears in journals such as Blood, Leukemia, PLoS ONE, Molecular Therapy and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.